FUSZ Catalysts (UPDATED Continuously).....We're closer

New Post Public Reply Private Reply Replies (2) Message Board
ki2018rom
371
FUSZ Catalysts (UPDATED Continuously).....We're closer now>>>>>>>> goal to up list ASAP. Propelling this to $5-$7 a share for Nasdaq of $4 or NYSE and beyond..... What news events can drop in the upcoming days and weeks?

* Meeting Michael Yorba, CEO Money, back down in Dallas about Rewards.com. Michael is doing a cable drop...debut NotifiTV
* BOD Announcements
* ORACLE - Already 8k deal, Joint PR coming, rollouts
* Marketo - Joint PR 'Here' signed, sealed and VP Executive Delivered, rollouts
* Rewards.com formal PR?
* Our deals are non-exclusive......
* Possible Gov't Contract teamed with Oracle, narrowed to Amazon and Oracle?
* YouTube, Twitter or LinkedIn?
* Microsoft?
* Facebook?
* Google?
* UBID?
* AIG?
* ORU?
* SAP?
* Health Care market announcements...NotifiHEALTH?
* 8k contract with any of the other half dozen major CRM players, total over 50, Salesforce?
* Dating site deal(s)
* PR'd Ignite Visibility, add'l news
* More Educational Institutions, school districts deals or announcements....NotifiTEACH
* Two or More Nationally known Real Estate Deals previously mentioned coming, maybe more
* Major Asian TelCom Starhub deal been in discussion
* Rich Bohn's full review expected "soon" will impact, influence other companies signing deals
* Anything else we don't know about can drop out of the air
Several BIG hints in latest SHAC call, Rory mentioned working on contracts, Major CRM player, global deal....

Now look....As Rory hinted a few weeks ago, 'he's gonna throw gas on the fire'. One thing I've learned, Rory always hints, then does, and there's been many, many hints.

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading